Clinical Trials Logo

Clinical Trial Summary

The safety and efficacy of a urinary catheter designed to prevent catheter associated urinary infections is studied.


Clinical Trial Description

This study is an open randomized controlled trial of 4 weeks duration. The intervention is a novel urinary catheter with an electromagnetic therapy to prevent catheter associated infections. The catheter is used in patients which require longterm urinary catheterization over at least 1 month.

The endpoint is bacteriological exam and the laboratory is blinded to the therapy status. Weekly urinary cultures are drawn and a sonication culture of the catheter tip is performed to detect and characterize the biofilm. A colonization rate of >95% is anticipated in the control arm. Therefore a 50% reduction in colonization can be detected with 54 patients, a 90% reduction in colonization can be detected with 20 patients with a power of 0.9. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02658903
Study type Interventional
Source Oxys Medical AG
Contact Christoph Scharf, MD
Phone ++41763322969
Email christoph.scharf@gmail.com
Status Recruiting
Phase Phase 1
Start date January 2016
Completion date January 2017

See also
  Status Clinical Trial Phase
Terminated NCT00560924 - Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women Phase 3
Completed NCT00195286 - Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections. Phase 4